Virtual Reality Treadmill Training for Aging
(V-TARGET Trial)
Trial Summary
What is the purpose of this trial?
Age-associated motor and cognitive deficits increase the risk of falls, a major cause of morbidity and mortality. Emerging evidence suggests that inflammatory mediators lead to impaired functional capacity and frailty in the elderly and suggests that immune system mediated inflammation in the brain play an important role in cognitive decline. Substantial literature has also demonstrated that age-targeted physical activity training are promising strategies for promoting the motor-cognitive process across the adult lifespan. Recently, the virtual reality (VR) application has been implemented in the neuropsychological rehabilitation settings suggesting that the VR-infused daily living activities may benefit the transfer of intervention outcomes and to promote autonomy in function of daily living such as cooking or grocery shopping. However, it remains unclear the effect of the VR-based exercise intervention (motor-cognitive impact) on older adults' cognitive function and fall prevention. The literature suggests that the similarity of VR exercises with real life activities may improve generalizability by extending the transfer of gains of training to everyday living and promote some aspects of quality of life in older adults. It is also unclear to what extent these aging-associated motor- cognitive changes may be affected by VR rehab games and whether systemic- and neuro-inflammation is ameliorated by this novel intervention in older adults. This purpose of this study is to design and implement a Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes (V-TARGET) intervention, focusing on adults (aged up to 75 years old). The study will compare the effects of V-TARGET intervention (self-paced treadmill-simulator exercise with VR rehab games) against a control group on motor-cognitive function, health-related quality of life (HRQOL), circulating inflammatory markers and cerebral/peripheral blood flow through this 5-week intervention (2 times/week, 30-minutes/session, 10 sessions total).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the V-TARGET treatment for aging?
Research shows that combining virtual reality with treadmill training can improve walking and balance in people with impairments. Additionally, virtual reality-based exercise programs have been found to enhance muscle strength and balance in older adults, suggesting potential benefits for aging individuals.12345
Is virtual reality treadmill training safe for older adults?
Research on virtual reality exercise programs, including immersive virtual reality (IVR) exergames, shows they are generally safe for older adults, with no reported adverse effects such as simulator sickness. Studies have demonstrated good usability and positive experiences, suggesting that these programs are a safe option for physical activity in older populations.23678
How is the V-TARGET treatment different from other treatments for aging-related walking and balance issues?
The V-TARGET treatment is unique because it combines virtual reality with treadmill training, which not only helps improve walking and balance but also enhances cognitive engagement by mimicking real-world walking conditions. This approach allows for more effective rehabilitation by simulating over ground walking, unlike traditional treadmill training that uses a constant speed.1291011
Research Team
Xiangli Gu
Principal Investigator
University of Texas at Arlington
Eligibility Criteria
This trial is for adults up to 75 years old who are interested in a study on how virtual reality-infused treadmill training can affect aging-related outcomes like motor-cognitive function and quality of life. Participants should be able to commit to a 5-week program with sessions twice a week.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 5-week V-TARGET intervention with VR-infused treadmill training, consisting of 10 sessions (2 times/week, 30 minutes/session)
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1-month post-intervention
Treatment Details
Interventions
- V-TARGET intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas at Arlington
Lead Sponsor